Related Experiment Video
Updated: Aug 17, 2026

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages
Published on: April 20, 2018
Pulmonary intravascular macrophages. Role in acute lung injury
1Center for Animal Resources and Comparative Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
PIMs, although present only in selected animal species, may provide a clue to the potential role of mononuclear phagocytes on the vascular side of the air-blood barrier in lung inflammation and injury. We know PIMs localize circulating pathogens to the lungs in animals and concentrate the inflammatory response in the lung parenchyma. In certain disease states-e.g., biliary cirrhosis-pulmonary phagocytes may develop in the pulmonary capillaries, placing the lungs at risk for pathogen localization and subsequent inflammation. The two experimental approaches described last in this article-induction of intravascular macrophages in the lungs of rodents or rabbits and the selective inhibition or destruction of PIMs-offer models to study the role of mononuclear phagocytes in lung injury. The cirrhotic rat, especially, offers a model to investigate the interaction between pulmonary phagocytes and liver disease, including the adhesive molecules necessary for monocytes to adhere and differentiate in pulmonary capillaries. We then can investigate whether such factors arise in human lungs. We now can determine selectively whether macrophages can cause lung injury and what mediators they may contribute to the complex interactions among inflammatory cells, cytokines, proteases, oxygen radicals, and lipid mediators that participate in early sepsis-induced lung injury.
Insights
Pulmonary intravascular macrophages (PIMs) may play a role in lung inflammation and injury by localizing pathogens. Studying PIMs in animal models can reveal their function in lung diseases and sepsis.
Area of Science:
- Pulmonary immunology
- Vascular biology
- Inflammatory disease
Background:
- Pulmonary intravascular macrophages (PIMs) are present in select species and may influence lung inflammation and injury.
- PIMs are known to localize pathogens to the lungs and concentrate inflammatory responses.
- In conditions like biliary cirrhosis, pulmonary phagocytes can develop in lung capillaries, increasing susceptibility to inflammation.
Purpose of the Study:
- To investigate the role of mononuclear phagocytes in lung inflammation and injury.
- To explore the interaction between pulmonary phagocytes and liver disease.
- To determine if macrophages can cause lung injury and identify contributing mediators.
Main Methods:
- Induction of intravascular macrophages in rodent and rabbit lungs.
- Selective inhibition or destruction of PIMs.
- Utilizing the cirrhotic rat model to study pulmonary phagocyte-liver disease interactions.
Main Results:
- Experimental models were developed to study PIMs and mononuclear phagocytes in lung injury.
- The cirrhotic rat model allows investigation of monocyte adhesion and differentiation in pulmonary capillaries.
- Potential to investigate the role of these factors in human lungs.
Conclusions:
- PIMs and pulmonary phagocytes are critical components in lung inflammation and injury.
- Animal models provide valuable insights into the mechanisms of lung damage involving macrophages.
- Further research can elucidate the specific mediators macrophages contribute to sepsis-induced lung injury.
Related Concept Videos
Inflammation
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Acute Inflammation I: Inflammatory Response
Acute Inflammation II: Cellular Phase
Acute Inflammation III: Local and Systemic Effects
Chronic Inflammation: Introduction

